Company

Therapeutic Human Polyclonals Inc.

Therapeutic Human Polyclonals Inc., based in Mountain View, sells domain names, including PolyClonals.com, directly to buyers.

About

Therapeutic Human Polyclonals Inc. operates as a domain name brokerage, selling domain names such as PolyClonals.com to entrepreneurs, small businesses and corporations, mainly in North America and Europe. PolyClonals.com is offered at USD 1,795 or in monthly payments of USD 74.79 over 24 months, with a 30-day money-back guarantee. Headquartered in Mountain View, US, the company was acquired by Roche for USD 56.50 million in March 2007, and its recorded stage is Series B.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in